These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38336791)

  • 41. Arrhythmogenic right ventricular cardiomyopathy: diverse substrate characteristics and ablation outcome.
    Cheng WH; Chung FP; Lin YJ; Lo LW; Chang SL; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang TY; Kuo L; Wu CI; Liu CM; Liu SH; Chen SA
    Rev Cardiovasc Med; 2021 Dec; 22(4):1295-1309. PubMed ID: 34957771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy.
    Miles C; Finocchiaro G; Papadakis M; Gray B; Westaby J; Ensam B; Basu J; Parry-Williams G; Papatheodorou E; Paterson C; Malhotra A; Robertus JL; Ware JS; Cook SA; Asimaki A; Witney A; Ster IC; Tome M; Sharma S; Behr ER; Sheppard MN
    Circulation; 2019 Apr; 139(15):1786-1797. PubMed ID: 30700137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Arrhythmogenic right-ventricular cardiomyopathy: different manifestations as precursors of sudden death which might be prevented].
    van der Harst P; Wiesfeld AC; van Gelder IC; van Tintelen JP; Suurmeijer AJ; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2396-402. PubMed ID: 15615276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nationwide (Denmark) study of symptoms preceding sudden death due to arrhythmogenic right ventricular cardiomyopathy.
    Sadjadieh G; Jabbari R; Risgaard B; Olesen MS; Haunsø S; Tfelt-Hansen J; Winkel BG
    Am J Cardiol; 2014 Apr; 113(7):1250-4. PubMed ID: 24513468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
    Alblaihed L; Kositz C; Brady WJ; Al-Salamah T; Mattu A
    Am J Emerg Med; 2023 Mar; 65():146-153. PubMed ID: 36638611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
    Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
    Protonotarios A; Anastasakis A; Panagiotakos DB; Antoniades L; Syrris P; Vouliotis A; Stefanadis C; Tsatsopoulou A; McKenna WJ; Protonotarios N
    Europace; 2016 Apr; 18(4):610-6. PubMed ID: 25825460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arrhythmogenic Right Ventricular Cardiomyopathy Post-Mortem Assessment: A Systematic Review.
    Cianci V; Forzese E; Sapienza D; Cianci A; Ieni A; Germanà A; Guerrera MC; Omero F; Speranza D; Cracò A; Asmundo A; Gualniera P; Mondello C
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical manifestations of arrhythmogenic right ventricular cardiomyopathy in Korean patients.
    Cho Y; Park T; Shin D; Lee JH; Ryu HM; Jang GL; Lee DY; Park Y; Lee H; Kim H; Shin SC; Heo JH; Kang H; Lee BR; Nah DY; Yang DH; Park HS; Chae SC; Jun JE; Park WH
    Int J Cardiol; 2007 Nov; 122(2):137-42. PubMed ID: 17254652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
    Molitor N; Hofer D; Çimen T; Gasperetti A; Akdis D; Costa S; Jenni R; Breitenstein A; Wolber T; Winnik S; Fokstuen S; Fu G; Medeiros-Domingo A; Ruschitzka F; Brunckhorst C; Duru F; Saguner AM
    Heart; 2023 Jul; 109(15):1146-1152. PubMed ID: 36889907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy.
    Rigato I; Bauce B; Rampazzo A; Zorzi A; Pilichou K; Mazzotti E; Migliore F; Marra MP; Lorenzon A; De Bortoli M; Calore M; Nava A; Daliento L; Gregori D; Iliceto S; Thiene G; Basso C; Corrado D
    Circ Cardiovasc Genet; 2013 Dec; 6(6):533-42. PubMed ID: 24070718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes.
    Taylor M; Graw S; Sinagra G; Barnes C; Slavov D; Brun F; Pinamonti B; Salcedo EE; Sauer W; Pyxaras S; Anderson B; Simon B; Bogomolovas J; Labeit S; Granzier H; Mestroni L
    Circulation; 2011 Aug; 124(8):876-85. PubMed ID: 21810661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy.
    Perrin MJ; Angaran P; Laksman Z; Zhang H; Porepa LF; Rutberg J; James C; Krahn AD; Judge DP; Calkins H; Gollob MH
    J Am Coll Cardiol; 2013 Nov; 62(19):1772-9. PubMed ID: 23810883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?
    Bennett RG; Haqqani HM; Berruezo A; Della Bella P; Marchlinski FE; Hsu CJ; Kumar S
    Heart Lung Circ; 2019 Jan; 28(1):164-177. PubMed ID: 30446243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arrhythmogenic Right Ventricular Cardiomyopathy.
    Krahn AD; Wilde AAM; Calkins H; La Gerche A; Cadrin-Tourigny J; Roberts JD; Han HC
    JACC Clin Electrophysiol; 2022 Apr; 8(4):533-553. PubMed ID: 35450611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease.
    Basso C; Fox PR; Meurs KM; Towbin JA; Spier AW; Calabrese F; Maron BJ; Thiene G
    Circulation; 2004 Mar; 109(9):1180-5. PubMed ID: 14993138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D): Review of 16 Pediatric Cases and a Proposal of Modified Pediatric Criteria.
    Deshpande SR; Herman HK; Quigley PC; Shinnick JK; Cundiff CA; Caltharp S; Shehata BM
    Pediatr Cardiol; 2016 Apr; 37(4):646-55. PubMed ID: 26743400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy.
    Bao J; Wang J; Yao Y; Wang Y; Fan X; Sun K; He DS; Marcus FI; Zhang S; Hui R; Song L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):552-6. PubMed ID: 24125834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy.
    van der Zwaag PA; van Rijsingen IA; Asimaki A; Jongbloed JD; van Veldhuisen DJ; Wiesfeld AC; Cox MG; van Lochem LT; de Boer RA; Hofstra RM; Christiaans I; van Spaendonck-Zwarts KY; Lekanne dit Deprez RH; Judge DP; Calkins H; Suurmeijer AJ; Hauer RN; Saffitz JE; Wilde AA; van den Berg MP; van Tintelen JP
    Eur J Heart Fail; 2012 Nov; 14(11):1199-207. PubMed ID: 22820313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.